LALPATHLAB Stock Overview
Dr. Lal PathLabs Limited engages in the operation of laboratories for carrying out pathological investigations in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 3/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Dr. Lal PathLabs Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹2,388.35 |
| 52 Week High | ₹2,767.10 |
| 52 Week Low | ₹1,888.10 |
| Beta | 0.28 |
| 1 Month Change | 4.99% |
| 3 Month Change | -0.51% |
| 1 Year Change | 22.20% |
| 3 Year Change | -18.56% |
| 5 Year Change | 128.69% |
| Change since IPO | 189.50% |
Recent News & Updates
Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital
Apr 13
These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Safely
Mar 06Recent updates
Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital
Apr 13These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Safely
Mar 06Dr. Lal PathLabs Limited Just Missed EPS By 5.4%: Here's What Analysts Think Will Happen Next
Feb 04Subdued Growth No Barrier To Dr. Lal PathLabs Limited's (NSE:LALPATHLAB) Price
Dec 28Is Dr. Lal PathLabs (NSE:LALPATHLAB) Using Too Much Debt?
Nov 17Dr. Lal PathLabs (NSE:LALPATHLAB) Will Be Hoping To Turn Its Returns On Capital Around
Oct 12Here's Why Dr. Lal PathLabs (NSE:LALPATHLAB) Can Manage Its Debt Responsibly
Jul 07Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital
Jun 10Dr. Lal PathLabs (NSE:LALPATHLAB) Could Be Struggling To Allocate Capital
Feb 13Is Dr. Lal PathLabs (NSE:LALPATHLAB) Using Too Much Debt?
Dec 29Dr. Lal PathLabs (NSE:LALPATHLAB) Will Want To Turn Around Its Return Trends
Sep 21These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Reasonably Well
Sep 01Dr. Lal PathLabs (NSE:LALPATHLAB) Will Pay A Dividend Of ₹6.00
Jul 31Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital
Jun 23Does This Valuation Of Dr. Lal PathLabs Limited (NSE:LALPATHLAB) Imply Investors Are Overpaying?
Jun 11These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Safely
May 25Do Dr. Lal PathLabs's (NSE:LALPATHLAB) Earnings Warrant Your Attention?
Apr 28Is Dr. Lal PathLabs (NSE:LALPATHLAB) A Risky Investment?
Feb 17With EPS Growth And More, Dr. Lal PathLabs (NSE:LALPATHLAB) Is Interesting
Jan 20Why You Should Care About Dr. Lal PathLabs' (NSE:LALPATHLAB) Strong Returns On Capital
Dec 06Here's Why I Think Dr. Lal PathLabs (NSE:LALPATHLAB) Might Deserve Your Attention Today
Oct 13Does Dr. Lal PathLabs (NSE:LALPATHLAB) Have A Healthy Balance Sheet?
Aug 26Shareholder Returns
| LALPATHLAB | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | 8.1% | 1.3% | 2.8% |
| 1Y | 22.2% | 64.0% | 46.6% |
Return vs Industry: LALPATHLAB underperformed the Indian Healthcare industry which returned 64% over the past year.
Return vs Market: LALPATHLAB underperformed the Indian Market which returned 46.6% over the past year.
Price Volatility
| LALPATHLAB volatility | |
|---|---|
| LALPATHLAB Average Weekly Movement | 4.2% |
| Healthcare Industry Average Movement | 6.4% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: LALPATHLAB has not had significant price volatility in the past 3 months.
Volatility Over Time: LALPATHLAB's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1949 | 4,048 | Bharath Uppiliappan | www.lalpathlabs.com |
Dr. Lal PathLabs Limited engages in the operation of laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers training programs.
Dr. Lal PathLabs Limited Fundamentals Summary
| LALPATHLAB fundamental statistics | |
|---|---|
| Market cap | ₹193.56b |
| Earnings (TTM) | ₹3.30b |
| Revenue (TTM) | ₹21.72b |
60.1x
P/E Ratio9.1x
P/S RatioIs LALPATHLAB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LALPATHLAB income statement (TTM) | |
|---|---|
| Revenue | ₹21.72b |
| Cost of Revenue | ₹9.28b |
| Gross Profit | ₹12.44b |
| Other Expenses | ₹9.14b |
| Earnings | ₹3.30b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 39.72 |
| Gross Margin | 57.27% |
| Net Profit Margin | 15.19% |
| Debt/Equity Ratio | 16.6% |
How did LALPATHLAB perform over the long term?
See historical performance and comparison